Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Presidential Memo Reinforces Unfavorable Outlook For PMA Pre-emption

This article was originally published in The Gray Sheet

Executive Summary

A May 20 White House policy statement on pre-emption suggests that if a pending bill to remove protections from state lawsuits for manufacturers of PMA-approved devices passes Congress, there is a good chance the president will sign it into law
Advertisement

Related Content

Senate Dems Argue That Device Safety Act Will Not Curb Innovation
Senate Dems Argue That Device Safety Act Will Not Curb Innovation
Device Industry Groups Lobby Against Bill That Would End PMA Pre-emption
In Victory For Device Industry, Supreme Court Favors PMA Pre-emption
In Victory For Device Industry, Supreme Court Favors PMA Pre-emption

Topics

Advertisement
UsernamePublicRestriction

Register

MT027483

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel